Jaguar Health Announces Reverse Stock Split

Jaguar Health, Inc. plans a reverse stock split, effective March 24, 2025, with a 1-for-25 ratio. This measure aims to comply with Nasdaq's listing standards. Post-split, shares will trade under the symbol "JAGX" on the Nasdaq Capital Market. The new CUSIP is 47010C888.

The decision, ratified at a Special Meeting of Stockholders, seeks to attract institutional investors by enhancing share price and count. Fractional shares will not be issued; cash payments will be given instead. Equiniti Trust Company, LLC oversees the process for stockholders to exchange certificates.

Jaguar Health, a pharmaceutical company, focuses on developing medications derived from plants for gastrointestinal issues. The reverse split aligns with their strategic goals.